Besifloxacin Hydrochloride
Who holds supplier records for Besifloxacin Hydrochloride? 4 organisations hold a current record for Besifloxacin Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Besifloxacin Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/besifloxacin-hydrochloride
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Besifloxacin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALP PHARM BEIJING CO LTDActive DMF 32611 · latest filing Mar 2018
- INDOCO REMEDIES LTDIndia Company GMP cert on recordActive DMF 29303 · latest filing Jul 2015
- MAITHRI DRUGS PRIVATE LTDIndia Company GMP cert on recordActive DMF 35809 · latest filing Mar 2021
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 31989 · latest filing Nov 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Besifloxacin Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- RUYUAN HEC PHARM CO LTDInactive DMF 32160 · filed Nov 2017
- SSP CO LTDInactive DMF 16249 · filed Nov 2002
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Besifloxacin Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201761).
Chemical identity
- IUPAC name
- 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid;hydrochloride
- Canonical SMILES
- C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl
- InChIKey
- PMQBICKXAAKXAY-HNCPQSOCSA-N
- Synonyms
- Besifloxacin (as hydrochloride), Besifloxacin hcl, Besifloxacin hydrochloride, Besivance, BOL-303224-A, SS-734, SS734, RefChem:56417, Besifloxacin (Hydrochloride), Besifloxacin hydrochloride [USAN], Besifloxacin HCl (Besivance), C19H22Cl2FN3O3
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Quinolone Antimicrobial
- Chemical structure
- Quinolones
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Besifloxacin Hydrochloride?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Besifloxacin Hydrochloride: ALP PHARM BEIJING CO LTD, INDOCO REMEDIES LTD (India), MAITHRI DRUGS PRIVATE LTD (India) and MICRO LABS LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Besifloxacin Hydrochloride Drug Master Files are active?
ALP PHARM BEIJING CO LTD (DMF 32611), INDOCO REMEDIES LTD (DMF 29303), MAITHRI DRUGS PRIVATE LTD (DMF 35809) and MICRO LABS LTD (DMF 31989). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Besifloxacin Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Besifloxacin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Besifloxacin Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Besifloxacin Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.